Menu

Category: News

Five New Tools for the Month of May

Published May 28, 2019

A number of new tools have been posted during the month of May.  A brief description of each tool is provided below.  Click on the each link to download the tools. Algorithm for Management of Suspected Urinary Tract Infections in Long-Term Care Residents: This tool precisely outlines clinical parameters that should be considered when a… Read More

How Nebraska ASAP Is Making Everyone Antibiotic Aware

Published November 15, 2018

Written by Dr. M. Salman Ashraf, Nebraska ASAP Co-Medical Director Antibiotic Resistance is one of the most urgent threats to the public health. Overuse and misuse of antibiotics allows the development of antibiotic-resistant bacteria. Unfortunately, a significant proportion of antibiotic use in various healthcare settings continues to be unnecessary or inappropriate. About a third (30%)… Read More

U.S. Antibiotic Awareness Week is November 12-18, 2018

Published November 6, 2018

This year the U.S. Antibiotic Awareness Week (USAAW) will run between November 12 to 18.  Organized by the CDC, this week long campaign brings awareness to healthcare professionals and the public on the threat of antibiotic resistance and the importance of using antibiotic appropriately. The CDC has prepared a partner toolkit for institutions that want… Read More

Implementing Antimicrobial Stewardship Efforts Across Different Healthcare Settings

Published August 8, 2018

 The CDC recommends implementation of antimicrobial stewardship efforts across various healthcare settings (acute, post-acute and long-term, and ambulatory care) as a way to improve antimicrobial prescribing and ultimately to improve patient safety and care.  Although various antimicrobial stewardship guidance documents serve as outlines for implementation, they are not detailed plans on how to bring AS… Read More

Regulatory Requirements for ASP in Different Healthcare Settings

Published August 1, 2018

By now, you are probably aware of the regulations and accreditation requirements for antimicrobial stewardship programs (ASP) in the acute, long-term, and ambulatory care settings.  If you don’t know or remember all the details, you can review the videos from Drs. Bergman’s and Dr. Crnich’s talks on these topics presented during the Nebraska Antimicrobial Stewardship… Read More

Management of Common Infections in Long-Term Care

Published July 25, 2018

During the Nebraska Antimicrobial Stewardship Summit on June 1st, 2018, Dr. Christopher Crnich from the University of Wisconsin at Madison delivered an excellent review on the management of common infections in long-term care.  Dr. Crnich reviewed the management of Clostridium difficile infections (CDI), and what he called ‘pus infections’ which included urinary tract infections (UTI),… Read More

New CDC Antibiotic Stewardship Training Targets Outpatient Settings

Published July 18, 2018

This week, CDC launched the second installment of the free web-based antibiotic stewardship training.  The first installment, which include 3 modules, was launched in February this year.  It provided an overview on the threat of antibiotic resistance and the benefits of antimicrobial stewardship programs in combating this threat.  The current installment, which is divided in… Read More

What Happened at the Nebraska Antimicrobial Stewardship Summit?

Published June 8, 2018

After almost a year of planning, the First Annual Nebraska Antimicrobial Stewardship Summit convened on Friday, June 1st, 2018 in La Vista, NE.  This conference is the first of its kind in Nebraska in which information on antimicrobial stewardship in various healthcare settings is the focus of the meeting.  The conference center was abuzz with… Read More

IDSA and SHEA Update Clostridium difficile Infection Clinical Practice Guidelines

Published March 15, 2018

Clostridium difficile* infections (CDI) are associated with significant morbidity and mortality in the United States.  Based on data from 2006 to 2011, studies estimated close to 500,000 CDI cases annually, resulting in 15,000 to 30,000 deaths and 4.8 million dollars in excess costs to acute care facilities.  C difficile infections remain a major public health problem,… Read More

FDA Issues New Safety Communication on Clarithromycin Use in Patients with Heart Disease

Published March 1, 2018

On February 22nd, the Food & Drug Administration (FDA) issued a new drug safety communication to health care providers regarding the long-term risks of clarithromycin use in patients with heart disease.  Clarithromycin is a macrolide antibiotic used for treatment of a variety of respiratory tract and skin infections, and infections caused by Helicobacter pylori and non-tuberculous… Read More

Page last reviewed: November 8, 2018